US Equity
RARE
— ULTRAGENYX PHARMACEUTICAL INC.Ultragenyx Pharmaceutical is a biopharmaceutical company focused on developing novel therapies for rare and ultra-rare genetic diseases.
💰 Market cap: $2.65B📍 60 Leveroni Ct, NOVATO, CA, 94949 US🏷️ Pharmaceuticals💵 Previous close: $26.90🔢 9,024 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $26.90 |
| 2026-07-23 | $27.02 |
| 2026-07-22 | $27.64 |
| 2026-07-21 | $28.62 |
| 2026-07-20 | $28.53 |
| 2026-07-17 | $29.28 |
| 2026-07-16 | $30.22 |
| 2026-07-15 | $31.71 |
| 2026-07-14 | $32.03 |
| 2026-07-13 | $33.22 |
| 2026-07-10 | $33.82 |
| 2026-07-09 | $34.61 |
| 2026-07-08 | $34.67 |
| 2026-07-07 | $35.87 |
| 2026-07-06 | $33.70 |
| 2026-07-02 | $33.47 |
| 2026-07-01 | $32.38 |
| 2026-06-30 | $33.39 |
| 2026-06-29 | $30.68 |
| 2026-06-26 | $30.77 |
| 2026-06-25 | $29.25 |
| 2026-06-24 | $29.11 |
| 2026-06-23 | $28.76 |
| 2026-06-22 | $29.03 |
| 2026-06-18 | $27.44 |
| 2026-06-17 | $26.91 |
| 2026-06-16 | $24.85 |
| 2026-06-15 | $25.38 |
| 2026-06-12 | $24.35 |
| 2026-06-11 | $23.98 |
| 2026-06-10 | $22.97 |
| 2026-06-09 | $22.79 |
| 2026-06-08 | $21.59 |
| 2026-06-05 | $21.91 |
| 2026-06-04 | $23.31 |
| 2026-06-03 | $22.41 |
| 2026-06-02 | $21.78 |
| 2026-06-01 | $22.85 |
| 2026-05-29 | $23.94 |
| 2026-05-28 | $23.26 |
| 2026-05-27 | $23.39 |
| 2026-05-26 | $23.14 |
| 2026-05-22 | $23.39 |
| 2026-05-21 | $23.71 |
| 2026-05-20 | $23.37 |
| 2026-05-19 | $22.45 |
| 2026-05-18 | $24.19 |
| 2026-05-15 | $25.00 |
| 2026-05-14 | $25.80 |
| 2026-05-13 | $26.46 |
| 2026-05-12 | $26.84 |
| 2026-05-11 | $26.30 |
| 2026-05-08 | $26.12 |
| 2026-05-07 | $26.13 |
| 2026-05-06 | $25.93 |
| 2026-05-05 | $25.01 |
| 2026-05-04 | $24.81 |
| 2026-05-01 | $24.77 |
| 2026-04-30 | $24.69 |
| 2026-04-29 | $24.18 |
| 2026-04-28 | $24.53 |